(1,3-DIMESITYL-IMIDAZOLIDINE-2-YLIDENE)-(PCY3)-(CL2)-RU=CF2
Compound with spectra: 1 NMR
| SpectraBase Compound ID | BUbrvo3pTXw |
|---|---|
| InChI | InChI=1S/C21H27N2.C18H33P.CF2.2ClH.Ru/c1-14-9-16(3)20(17(4)10-14)22-7-8-23(13-22)21-18(5)11-15(2)12-19(21)6;1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;2-1-3;;;/h9-13H,7-8H2,1-6H3;16-18H,1-15H2;;2*1H;/q;;;;;+1/p-1 |
| InChIKey | YVSXCAICICJBBI-UHFFFAOYSA-M |
| Mol Weight | 810.9 g/mol |
| Molecular Formula | C40H61Cl2F2N2PRu |
| Exact Mass | 810.296089 g/mol |
| Parent InChIKey | AJTQTERUXKDDJY-UHFFFAOYSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
(1,3-DIMESITYL-IMIDAZOLIDINE-2-YLIDENE)-(PCY3)-(CL2)-RU=CH(OET)
RZZJLQIXIJPVFY-UHFFFAOYSA-M
4-(allylsulfanyl)-5-cyano-2-hydroxy-2-methyl-N-phenyl-3-azaspiro[5.5]undec-4-ene-1-carboxamide
1-(5,8-Dimethoxy-4,4-dimethyl-6-nitro-3,4-dihydroquinolin-1(2H)-yl)ethanone
2H-1-Benzopyran-3-ol, 2-(cyclohexyloxy)-3,4-dihydro-2-(4-methoxyphenyl)-, 4-methylbenzenesulfonate, trans-(.+-.)-
Benzamide, N-[6-methyl-8-(2-oxopropylidene)-1,3-dioxolo[4,5-g]quinazolin-7(8H)-y l]-
Methanone, [7-(4-chlorophenyl)-4,7-dihydro-5-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-6-yl](4-fluorophenyl)-
ALPHA-NEO-THIO-BINUPHARIDINE-SULFOXIDE
2-(4-Chlorophenylamino)-5-methyl-3-aminopyrimido[5,4-c]quinolin-4(3H)-one
4-ALPHA,5,8-TRIHYDROXY-ALPHA-TETRALONE-5-O-BETA-D-[6'-O-(3'',4'',5''-TRIHYDROXYBENZOYL)]-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Activity of Ruthenium Alkylidene Complexes Coordinated with Phosphine and N-Heterocyclic Carbene Ligands | Journal of the American Chemical Society | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.